| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 9, 2024 |
| Accession Number: | 0001140361-24-048135 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/10/2024 | $60.00 | Buy | Truist |
| 7/1/2024 | $60.00 → $90.00 | Overweight | Cantor Fitzgerald |
| 5/1/2024 | $36.00 | Outperform | Robert W. Baird |
| 2/16/2024 | $40.00 | Buy | Citigroup |
| 10/24/2023 | $16.00 → $35.00 | Overweight | Cantor Fitzgerald |
| 4/27/2023 | $13.00 | Buy | B. Riley Securities |
| 2/14/2022 | $14.00 | Outperform | Wedbush |
15-12G - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)
POSASR - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)
RW WD - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)